Page last updated: 2024-10-28

guanfacine and Labhart-Willi Syndrome

guanfacine has been researched along with Labhart-Willi Syndrome in 1 studies

Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singh, D1
Kadakia, N1
Pinkhasov, A1

Other Studies

1 other study available for guanfacine and Labhart-Willi Syndrome

ArticleYear
Significant reduction of aggression with guanfacine extended release in an adolescent with Prader-Willi syndrome.
    Journal of child and adolescent psychopharmacology, 2015, Volume: 25, Issue:4

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Aggression; Delayed-Action Preparations; Female; G

2015